Ideal Cures

What Ideal Cures does

Ideal Cures Pvt. Ltd. is an India-based specialty pharmaceutical excipient manufacturer headquartered in Mumbai, with manufacturing operations in Jammu, Khambhat, and Vasai and a fourth facility in Sikkim under EXCiPACT certification. Founded in 1990 and operating for 25+ years, the company supplies ready-to-use coating systems, acrylic polymers, neutral pellets, extended cooling compounds, taste masking agents, and controlled-release excipients to pharmaceutical, nutraceutical, Ayurvedic/herbal, and confectionery manufacturers in 65+ countries. The product portfolio is organized around six proprietary brand families: INSTACOAT (film coating, including general purpose, moisture barrier, delayed release, sugar coating, multi-functional and nutraceutical grades), ECOPOL (methacrylic acid and ethyl acrylate / methyl methacrylate copolymers for enteric and colonic delivery), ECOCOOL (extended cooling boosters), ESPHERES (microcrystalline cellulose, silicon dioxide, calcium carbonate, tartaric acid and sugar spheres), INSTANUTE (nutraceutical coatings), and INSTAMASK (taste masking), supported by INSTAMODEL, a predictive-modeling extended release expert system. Ideal Cures holds 16 granted patents, US DMF filings (Type IV No. 25645 and 030191), ISO 9001:2015, cGMP, and EXCiPACT certifications, and product monographs in Ph. Eur., USPNF, and JPE.

The company operates a sales-led, direct-to-manufacturer go-to-market model, engaging customers through inquiry-based contact, sales representatives, technical and regulatory support from formulation development through commercialization, and the IDEAL Institute of Coating Technology training program. Revenue is generated primarily through one-time product sales of excipient and coating system SKUs, supplemented by technical and regulatory professional services; pricing is not publicly disclosed and is provided via quote-based inquiry. The customer base spans large generic-drug manufacturers, specialty pharma, nutraceutical brands, Ayurvedic producers, and confectionery companies, with no named reference customers publicly disclosed. Ownership is concentrated among founder/management, with Dr. Maulek Desai serving as Managing Director, Dinesh Pandey as GM Finance and Board member, and functional GMs leading marketing, supply chain, and HR.

The business is privately held, self-funded (no disclosed external funding rounds), and has executed no disclosed M&A. Recent strategic activity has focused on (i) capacity expansion through the Sikkim plant, (ii) portfolio diversification into nutraceuticals, taste masking, and anti-counterfeiting coatings, (iii) proactive regulatory positioning ahead of EU restrictions on titanium dioxide (INSTACOAT T2F), and (iv) organizational professionalization through senior functional leadership hires since 2022.

Name

Ideal Cures

Legal name

Ideal Cures Pvt. Ltd.

Website

https://www.idealcures.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

251–500 employees

Short description

Ideal Cures is an India-based specialty pharmaceutical excipient manufacturer producing ready-to-use film coating systems, acrylic polymers, neutral pellets, cooling compounds, and taste masking agents under the INSTACOAT, ECOPOL, ECOCOOL, and ESPHERES brands. It sells to pharmaceutical, nutraceutical, Ayurvedic, and confectionery manufacturers across 65+ countries.

Ownership category

akta.pro rank

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Excipients and Coating Systems Sales: Sale of ready-to-use film coating systems, pharma acrylic polymers, neutral pellets, extended cooling boosters, and related excipients to pharmaceutical, nutraceutical, and allied industries globally.
2. Technical and Regulatory Services: Technical support services from formulation development through post-commercialization, including regulatory compliance support and application laboratories.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Ideal Cures manufactures and exports ready-to-use pharmaceutical film coating systems, pharma acrylic polymers, neutral pellets, extended cooling compounds, taste masking agents, and controlled release excipients for solid oral dosage forms. The company serves pharmaceutical, nutraceutical, Ayurvedic, herbal, and confectionery manufacturers across 65+ countries, complemented by technical and regulatory support from formulation development through commercialization.

Product overview

Ideal Cures is a pharmaceutical excipient and ready-to-use coating systems manufacturer serving the solid oral dosage forms industry. The company's product portfolio operates as a multi-brand platform organized into six core categories: Film Coating Systems (INSTACOAT brand including general purpose, moisture barrier, delayed release, sugar coating, multi-functional, and nutraceutical coatings), Pharma Acrylic Polymers (ECOPOL brand for enteric/delayed release applications), Extended Cooling Boosters (ECOCOOL brand for cooling sensations), Neutral Pellets (ESPHERES brand for spheroid excipients and INSTASPHERES seal-coated variants), Taste Masking Agents (INSTAMASK for bitter API masking), and Controlled Release Products (INSTAMODEL for extended release formulations). The INSTACOAT line alone comprises over 30 distinct formulations including general-purpose coatings (INSTACOAT 4G, Aqua series, Universal, Sol, P4), moisture barriers (EMB, Instamoistshield), delayed/enteric releases (EN Super II/IV, EEN series, EN-HPMC-P, EN SOL), sugar coatings (Sugar Fast, Chewable Fast), multi-functional coatings (Spectrum, Unique, SMART, Flavour, Herbo, Natcol), and supporting products (INSTASPRAY, INSTACOAT Colour, INSTAGLOW). The ECOPOL acrylic polymer family includes four grades with different copolymer ratios and forms. This comprehensive portfolio is complemented by technical and regulatory support services, serving pharmaceutical, nutraceutical, Ayurvedic, and confectionery customers across 65+ countries.

Differentiator

Problem solved

Functional benefit

Brands

• INSTACOAT®: Ready-to-use film coating systems for solid oral dosage forms
• ECOPOL®
• ECOCOOL®
• ESPHERES®
• INSTANUTE®
• ICPL

Products and services

• INSTACOAT 4G Ready-mixed powder film coating system reconstituted in water for solid oral dosage forms, with anti-tack agent and PVA-based formulation achieving up to 35% solids levels. Designed for pharmaceutical manufacturers requiring high-solids rapid coating.
• INSTACOAT QD Quick disintegrating aqueous film coating system optimized for rapid disintegration, allowing early core exposure and faster API onset of action for pharmaceutical manufacturers.
• INSTACOAT T2F Titanium Dioxide and Talc free film coating system for pharmaceutical and nutraceutical applications using label-friendly colorants.
• INSTACOAT Sugar Fast Coatings HPMC and sucrose based high productivity aqueous sugar film coating system offering attractive appearance and taste of conventional sugar-coating for confectionery manufacturers.
• INSTACOAT EMB PVA-based high performance aqueous moisture barrier coating system reducing degradation of moisture sensitive APIs and extending shelf-life for pharmaceutical manufacturers.
• INSTACOAT EN Super II Fully formulated enteric coating system based on Methacrylic Acid Copolymer Type C for aqueous reconstitution, achieving reliable enteric protection at 8-12% weight gain.
• INSTACOAT EEN SF Acrylic-based enteric coating formulation providing enteric protection at weight gain levels as low as 5% for cost savings for pharmaceutical manufacturers.
• INSTACOAT Spectrum Anti-counterfeiting technology providing multi-colour appearance on tablet surfaces that is difficult to reproduce with standard formulations for brand protection.
• INSTANUTE Delayed Release Ready-to-use film coating system based on Sodium Alginate for nutritional applications requiring delayed release properties for nutraceutical manufacturers.
• INSTANUTE Immediate Release HPMC-based ready-to-use film coating system for nutritional applications with enhanced core stabilization formulation for nutraceutical manufacturers.
• ECOPOL L 30D-55 Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) as 30% aqueous dispersion for enteric/delayed release coating for pharmaceutical manufacturers.
• ECOPOL S 100 Methacrylic Acid and Methyl Methacrylate Copolymer (1:2) dry powder for enteric/delayed release coating and colonic drug delivery for pharmaceutical manufacturers.
• ECOCOOL Extended cooling formulations providing prolonged cooling sensation for nutraceutical, herbal, cosmetic and pharmaceutical products, available in pellets, granules, powders, and solutions.
• INSTAMASK Taste masking product using polymer resin complexes for bitter APIs to increase patient compliance in pediatric and geriatric formulations for pharmaceutical manufacturers.
• INSTAMODEL Blend Expert system for Extended Release tablet formulations using proprietary HPMC matrix blends with predictive modeling for drug delivery, providing start-up formulations and technical support.
• Espheres EM Microcrystalline Cellulose spheres as hard free flowing spherical masses for modified release formulations and drug loading. GRAS-ingredients compliant with major pharmacopoeias.
• InstaSpheres Ready seal-coated spherical pellets available in sucrose, microcrystalline cellulose, colloidal silicon dioxide, and tartaric acid variants for pharmaceutical manufacturers.
• INSTACOAT Universal Versatile film coating system usable with organic, hydro-alcoholic, and aqueous solvent systems, employing water-soluble cellulosic materials for manufacturing flexibility.
• INSTACOAT Aqua General-purpose HPMC-based film coating system optimized for superior tablet finish using water as solvent for pharmaceutical manufacturers.
• Technical and Regulatory Support Services Technical and regulatory support from formulation development through commercialization, including application laboratories, regulatory compliance support, and the IDEAL Institute of Coating Technology training program for R&D scientists and healthcare professionals.

Quantifiable outcome

• Rapid coating with high solids capability up to 35% (Instacoat 4G) reducing process time
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• BASF: BASF's pharmaceutical excipients and coatings business offers ready-to-use film coating systems (e.g., Kollicoat) and a broad polymer portfolio that competes with Ideal Cures across both general and functional coatings.
• Roquette: Roquette is a major global supplier of pharmaceutical excipients including starches, cellulosics, and cyclodextrins, with a growing film coating presence that overlaps with Ideal Cures' coating and polymer business.
• Evonik Industries: Evonik is a global specialty chemicals major whose Health Care business supplies methacrylic copolymers (e.g., EUDRAGIT) for enteric and sustained-release coatings, directly overlapping with Ideal Cures' ECOPOL acrylic polymer portfolio.
• Kerry Group: Kerry's pharma and nutraceutical ingredient portfolio includes taste-masking, coating, and functional excipient technologies that compete with Ideal Cures' INSTAMASK and nutraceutical coating offerings.
• IFF (DuPont Pharma Solutions): IFF's Pharma Solutions business (formerly DuPont) supplies pharma-grade polymers, coating systems, and excipients including HPMC and methacrylic copolymers, making it a broad incumbent competitor to Ideal Cures' full polymer and coating range.
• Ashland: Ashland's Life Sciences division produces pharmaceutical coatings, controlled-release polymers, and specialty excipients, serving the same solid oral dosage form customers as Ideal Cures from a larger global footprint.
• Merck KGaA (Life Science): Merck's Life Science sector supplies a broad portfolio of pharma excipients, polymers, and formulation services for solid dosage forms, serving as a broad incumbent that competes with Ideal Cures in regulated pharmaceutical markets.

Direct peers

• Colorcon: Colorcon is the closest direct peer and global leader in film coating systems and excipients for the pharmaceutical industry, competing head-to-head with Ideal Cures' INSTACOAT line across ready-to-use coatings, modified release polymers, and functional excipients.
• Seppic (Air Liquide): Seppic provides ready-to-use film coating systems (e.g., SEPIFILM) and specialty excipients for oral solid dosage forms, positioning it as a direct peer in the same ready-to-use coating category as Ideal Cures.
• Shin-Etsu Chemical: Shin-Etsu Chemical supplies hypromellose (HPMC) and other cellulosic excipients used in film coatings and controlled-release matrices, directly competing with the cellulosic basis of Ideal Cures' INSTACOAT Aqua and related product lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/idealcures
• Facebookfacebook.com/profile.php
• LinkedInin.linkedin.com/company/ideal-cures-pvt.-ltd

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ideal Cures